StonvexLoading…
StonvexStonvexStonvexCore line items from UGI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.73B | $2.06B | $7.15B | $5.98B |
Operating Income | $1.21B | $454.00M | $1.11B | $1.09B |
Net Income | $817.00M | $297.00M | $678.00M | $691.00M |
EPS (Diluted) | $3.68 | $1.34 | $3.09 | $3.16 |
Total Assets | $16.12B | $15.81B | $15.46B | $15.36B |
Total Liabilities | $10.69B | $10.80B | $10.68B | $10.48B |
Cash & Equivalents | $494.00M | $251.00M | $335.00M | $350.00M |
Free Cash Flow OCF − CapEx | $339.00M | $-155.00M | $390.00M | $558.00M |
Shares Outstanding | 222.07M | 221.42M | 219.16M | 218.42M |